Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11899)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Mar 21, 2015 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Murayama Y, Oritani K, Tsutsui S. Novel CD9-targeted therapies in gastric cancer. World J Gastroenterol 2015; 21(11): 3206-3213 [PMID: 25805926 DOI: 10.3748/wjg.v21.i11.3206] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i11/3206.htm |
| Number | Citing Articles |
| 1 |
Ozan Yazici, M Ali Nahit Sendur, Nuriye Ozdemir, Sercan Aksoy. Targeted therapies in gastric cancer and future perspectives. World Journal of Gastroenterology 2016; 22(2): 471-489 doi: 10.3748/wjg.v22.i2.471
|
| 2 |
Hyun Min Koh, Bo Gun Jang, Dong Hui Lee, Chang Lim Hyun. Increased CD9 expression predicts favorable prognosis in human cancers: a systematic review and meta-analysis. Cancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-02152-y
|
| 3 |
Silio Lima Moura, Mercè Martì, María Isabel Pividori. Matrix Effect in the Isolation of Breast Cancer-Derived Nanovesicles by Immunomagnetic Separation and Electrochemical Immunosensing—A Comparative Study. Sensors 2020; 20(4): 965 doi: 10.3390/s20040965
|
| 4 |
Danielle R. Bond, Richard Kahl, Joshua S. Brzozowski, Helen Jankowski, Crystal Naudin, Mamta Pariyar, Kelly A. Avery-Kiejda, Christopher J. Scarlett, Claude Boucheix, William J. Muller, Leonie K. Ashman, Murray J. Cairns, Séverine Roselli, Judith Weidenhofer. Tetraspanin CD9 is Regulated by miR-518f-5p and Functions in Breast Cell Migration and In Vivo Tumor Growth. Cancers 2020; 12(4): 795 doi: 10.3390/cancers12040795
|
| 5 |
Maryam Noor Rizwan, Yunxia Ma, Miljana Nenkov, Lai Jin, Desiree Charlotte Schröder, Martin Westermann, Nikolaus Gaßler, Yuan Chen. Tumor‐derived exosomes: Key players in non‐small cell lung cancer metastasis and their implication for targeted therapy. Molecular Carcinogenesis 2022; 61(3): 269 doi: 10.1002/mc.23378
|
| 6 |
PAI-YUN LI, JING LV, WEI-WEI QI, SHU-FEN ZHAO, LI-BIN SUN, NING LIU, JIE SHENG, WEN-SHENG QIU. Tspan9 inhibits the proliferation, migration and invasion of human gastric cancer SGC7901 cells via the ERK1/2 pathway. Oncology Reports 2016; 36(1): 448 doi: 10.3892/or.2016.4805
|
| 7 |
Peiqi Liang, Miao Miao, Zhuogang Liu, Hongtao Wang, Wei Jiang, Shiyu Ma, Chuan Li, Rong Hu. CD9 expression indicates a poor outcome in acute lymphoblastic leukemia. Cancer Biomarkers 2018; 21(4): 781 doi: 10.3233/CBM-170422
|
| 8 |
Plaboni Sen, Siddhartha Sankar Ghosh. Targeting Cross‐Talks of Notch and VEGF to Tweak the EMT and EPT Dynamics in Triple Negative Breast Cancer Cells. Advanced Therapeutics 2024; doi: 10.1002/adtp.202400059
|
| 9 |
Felipe Vences-Catalán, Shoshana Levy. Immune Targeting of Tetraspanins Involved in Cell Invasion and Metastasis. Frontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.01277
|
| 10 |
Chunyuan Yang, Nan Chen, Xiang Li, Dan Lu, Zhiyuan Hou, Yuhua Li, Yan Jin, Jin Gu, Yuxin Yin. Mutations in the coat complex II component SEC23B promote colorectal cancer metastasis. Cell Death & Disease 2020; 11(3) doi: 10.1038/s41419-020-2358-7
|
| 11 |
Clodomiro Cafolla, James Philpott-Robson, Aaron Elbourne, Kislon Voïtchovsky. Quantitative Detection of Biological Nanovesicles in Drops of Saliva Using Microcantilevers. ACS Applied Materials & Interfaces 2024; 16(1): 44 doi: 10.1021/acsami.3c12035
|
| 12 |
Suhasini P.C., Shilpa Shetty, Suchetha Nalilu, Praveen Shetty, Prakash Patil. Tetraspanin CD9: A friend or foe of head and neck cancer (Review). Oncology Reports 2022; 47(5) doi: 10.3892/or.2022.8299
|
| 13 |
Hisanori Matsumoto, Yukiyasu Sato, Akihito Horie, Koh Suginami, Hirohiko Tani, Akira Hattori, Yoshihiko Araki, Kyosuke Kagami, Ikuo Konishi, Hiroshi Fujiwara. CD9 suppresses human extravillous trophoblast invasion. Placenta 2016; 47: 105 doi: 10.1016/j.placenta.2016.09.014
|
| 14 |
Carole Brosseau, Luc Colas, Antoine Magnan, Sophie Brouard. CD9 Tetraspanin: A New Pathway for the Regulation of Inflammation?. Frontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.02316
|
| 15 |
Heng Liang Tan, Andre Choo. Opportunities for Antibody Discovery Using Human Pluripotent Stem Cells: Conservation of Oncofetal Targets. International Journal of Molecular Sciences 2019; 20(22): 5752 doi: 10.3390/ijms20225752
|
| 16 |
Aurelio Lorico, Marco Lorico-Rappa, Jana Karbanová, Denis Corbeil, Giuseppe Pizzorno. CD9, a tetraspanin target for cancer therapy?. Experimental Biology and Medicine 2021; 246(9): 1121 doi: 10.1177/1535370220981855
|
| 17 |
Yue Deng, Sicheng Cai, Jian Shen, Huiming Peng. Tetraspanins: Novel Molecular Regulators of Gastric Cancer. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.702510
|
| 18 |
Beatriz Cardeñes, Irene Clares, Víctor Toribio, Lucía Pascual, Soraya López-Martín, Alvaro Torres-Gomez, Ricardo Sainz de la Cuesta, Esther M. Lafuente, Manuel López-Cabrera, María Yáñez-Mó, Carlos Cabañas. Cellular Integrin α5β1 and Exosomal ADAM17 Mediate the Binding and Uptake of Exosomes Produced by Colorectal Carcinoma Cells. International Journal of Molecular Sciences 2021; 22(18): 9938 doi: 10.3390/ijms22189938
|
| 19 |
Chenzhao Feng, Tianyu Xiang, Zixuan Yi, Xinyao Meng, Xufeng Chu, Guiyang Huang, Xiang Zhao, Feng Chen, Bo Xiong, Jiexiong Feng. A Deep-Learning Model With the Attention Mechanism Could Rigorously Predict Survivals in Neuroblastoma. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.653863
|
| 20 |
Shota Oyama, Tsuyoshi Yamamoto, Asako Yamayoshi. Recent Advances in the Delivery Carriers and Chemical Conjugation Strategies for Nucleic Acid Drugs. Cancers 2021; 13(15): 3881 doi: 10.3390/cancers13153881
|
| 21 |
Yang Li, Jia-qi Li, Hai-ping Jiang, Xin Li, Fu Wang. The Upregulation of PLXDC2 Correlates with Immune Microenvironment Characteristics and Predicts Prognosis in Gastric Cancer. Disease Markers 2021; 2021: 1 doi: 10.1155/2021/5669635
|
| 22 |
P. C. Suhasini, Vadisha Bhat, Shilpa S Shetty, Praveen Kumar Shetty, P. G. Roopashree, N. Suchetha Kumari. High expression of CD9 and Epidermal Growth Factor Receptor promotes the development of tongue cancer. Medical Oncology 2024; 41(4) doi: 10.1007/s12032-024-02311-x
|
| 23 |
Shi-Wei Chen, Qing Zhang, Zhi-Feng Xu, Hai-Ping Wang, Yi Shi, Feng Xu, Wen-Jian Zhang, Ping Wang, Yong Li. HOXC6 promotes gastric cancer cell invasion by upregulating the expression of MMP9. Molecular Medicine Reports 2016; 14(4): 3261 doi: 10.3892/mmr.2016.5640
|
| 24 |
Mujib Ullah, Asma Akbar, Avnesh S. Thakor. An emerging role of CD9 in stemness and chemoresistance. Oncotarget 2019; 10(40): 4000 doi: 10.18632/oncotarget.27021
|
| 25 |
Yaoyue Qi, Hui Li, Jing Lv, Weiwei Qi, Liwei Shen, Shihai Liu, Aiping Ding, Gongjun Wang, Libin Sun, Wensheng Qiu. Expression and function of transmembrane 4 superfamily proteins in digestive system cancers. Cancer Cell International 2020; 20(1) doi: 10.1186/s12935-020-01353-1
|
| 26 |
Tilman Schlothauer, Sylvia Herter, Claudia Ferrara Koller, Sandra Grau-Richards, Virginie Steinhart, Christian Spick, Manfred Kubbies, Christian Klein, Pablo Umaña, Ekkehard Mössner. Novel human IgG1 and IgG4 Fc-engineered antibodies with completely abolished immune effector functions. Protein Engineering Design and Selection 2016; 29(10): 457 doi: 10.1093/protein/gzw040
|
| 27 |
Xianjing Chu, Wentao Tian, Jiaoyang Ning, Gang Xiao, Yunqi Zhou, Ziqi Wang, Zhuofan Zhai, Guilong Tanzhu, Jie Yang, Rongrong Zhou. Cancer stem cells: advances in knowledge and implications for cancer therapy. Signal Transduction and Targeted Therapy 2024; 9(1) doi: 10.1038/s41392-024-01851-y
|
| 28 |
Ya-Kun Jiang, Wei Li, Ying-Yang Qiu, Meng Yue. Advances in targeted therapy for human epidermal growth factor receptor 2 positive in advanced gastric cancer. World Journal of Gastrointestinal Oncology 2024; 16(6): 2318-2334 doi: 10.4251/wjgo.v16.i6.2318
Abstract(183) |
Core Tip(195) |
Full Article(HTML)(1048)
|
Full Article with Cover (PDF)-10337K(38)
|
Audio-441K(3)
|
Peer-Review Report-231K(19)
|
Answering Reviewers-70K(17)
|
Supplementary Material-8723K(20)
|
Full Article (PDF)-10027K(62)
|
Full Article (XML)-321K(22)
|
Times Cited (0)
|
Total Visits (1946)
|
Open
|
| 29 |
Hee Jung Kwon, Jung Eun Choi, Su Hwan Kang, Youlim Son, Young Kyung Bae. Prognostic significance of CD9 expression differs between tumour cells and stromal immune cells, and depends on the molecular subtype of the invasive breast carcinoma. Histopathology 2017; 70(7): 1155 doi: 10.1111/his.13184
|
| 30 |
Arnau Pallares-Rusiñol, Mireia Bernuz, Silio Lima Moura, Carolina Fernández-Senac, Rosanna Rossi, Mercè Martí, María Isabel Pividori. . Advances in Clinical Chemistry 2023; 112: 69 doi: 10.1016/bs.acc.2022.09.002
|
| 31 |
Corina Schneidawind, Johan Jeong, Dominik Schneidawind, In-Suk Kim, Jesús Duque-Afonso, Stephen Hon Kit Wong, Masayuki Iwasaki, Erin H. Breese, James L. Zehnder, Matthew Porteus, Michael L. Cleary.
MLL leukemia induction by t(9;11) chromosomal translocation in human hematopoietic stem cells using genome editing. Blood Advances 2018; 2(8): 832 doi: 10.1182/bloodadvances.2017013748
|